Jan 29 2010
Merge
Healthcare (NASDAQ: MRGE) has successfully deployed its etrials
eDiary 5.0 platform to conduct a global Phase II urology clinical
trial involving 750 patients for one of the largest pharmaceutical
companies in the world. Merge was awarded the project because of its
eDiary technology, experience in global ePRO (electronic patient
reported outcomes) trials and ability to manage the complex logic
required by this study. Underway in 22 countries on 3 continents and in
34 languages, the trial also utilizes Merge’s new eDiary Inventory
Module to track shipping and supply of study devices in real-time.
“This is the first study deployed on our new ruggedized handheld device
platform and version 5.0 software, which builds on our 9-years of
experience providing eDiaries using the Windows Mobile® operating
system”
Patient reported information is increasingly critical to the success of
a clinical trial, but the data is prone to subjectivity, and is
difficult to economically collect in a timely and scientifically valid
manner. Handheld devices that upload patient-entered responses in real
time into centralized electronic repositories provide fast and accurate
data to clinical trials managers and can reduce overall trial costs.
Merge has conducted hundreds of global ePRO trials and can provide
solutions optimized to meet the needs of each individual trial and
sponsor.
“This is the first study deployed on our new ruggedized handheld device
platform and version 5.0 software, which builds on our 9-years of
experience providing eDiaries using the Windows Mobile® operating
system,” says Jon DeVries, Merge President. “The selection of etrials
eDiary for this very large trial is the latest validation of our
expertise in deploying state-of-the-art eDiary devices in complex global
trials. In combination with our integrated Web-based etrials
Synchronized Intelligence suite of solutions, which also includes
electronic data capture (EDC) and interactive voice and Web response
(IVR / IWR) technologies, Merge can provide clinical trials sponsors
with the customized tools they need to conduct clinically and
financially successful studies.”
SOURCE Merge Healthcare
Empowering lived experience in healthcare research